Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by dardanion Aug 31, 2016 10:43am
159 Views
Post# 25195096

RE:RE:RE:New KE Report

RE:RE:RE:New KE Report
One of the reasons Roger puts to less than stellar TLC-2000 sales is that practitioners were on summer holidays and they didn't want an expensive piece of equipment sitting idle in their clinics. I don't know how that washes with investors but for me it's a rather weak argument. In the first place, it would be rare for a self employed practitioner to take more than 2 weeks holiday from their practice. Whether it's patient demands or just having to pay the large bills to keep a clinic functioning, a doctor couldn't go off on any lengthy holiday. TLT  builds the TLC-2000 as the orders come in so the practitioner would have lot's of time to go on his holiday while the TLC-2000 is being built. If by chance he doesn't make it back and the unit is ready to be shipped then I'm sure the TLT sales staff would work with the buyer in making a slight adjustment to their shipping date to coincide with when the buyer is back in his office. Hopefully in future Roger will refrain from offering his shareholders such weak excuses to cover up the fact he is badly behind schedule on his commitment to deliver investors $5 million in gross device division revenue by the end of calendar 2016.
Bullboard Posts